Recombinant Human SLC27A2 Protein

Recombinant Human SLC27A2 Protein
Recombinant Human SLC27A2 Protein
   
NEU
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
ABS-PQ-3963.20 20 µg - -

10 - 14 Werktage*

270,00 €
ABS-PQ-3963.100 100 µg - -

10 - 14 Werktage*

540,00 €
 
Tag: N-MBP & C-His. Modification: unmodified. Start Site: Asn491. End Site: Leu620. Coverage:... mehr
Produktinformationen "Recombinant Human SLC27A2 Protein"
Tag: N-MBP & C-His. Modification: unmodified. Start Site: Asn491. End Site: Leu620. Coverage: 0.21. Isoelectric Point: 5.5. Core Sequence: NVATTEVADT VGLVDFVQEV NVYGVHVPDH EGRIGMASIK MKENHEFDGK KLFQHIADYL PSYARPRFLR IQDTIEITGT FKHRKMTLVE EGFNPAVIKD ALYFLDDTAK MYVPMTEDIY NAISAKTLKL. Homologies: Highest protein sequence identity to the following orthologs: Mouse - 84%, Rat - 86%, Pig - 89%, Cynomolgus monkey - 98%, Protein Function: Mediates the import of long-chain fatty acids (LCFA) into the cell by facilitating their transport across cell membranes, playing an important role in hepatic fatty acid uptake (PubMed:10198260, PubMed:10749848, PubMed:11980911, PubMed:20530735, PubMed:22022213, PubMed:24269233). Also functions as an acyl-CoA ligase catalyzing the ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-chain fatty acids (VLCFA) as substrates, which prevents fatty acid efflux from cells and might drive more fatty acid uptake (PubMed:10198260, PubMed:10749848, PubMed:11980911, PubMed:20530735, PubMed:22022213, PubMed:24269233). Plays a pivotal role in regulating available LCFA substrates from exogenous sources in tissues undergoing high levels of beta-oxidation or triglyceride synthesis (PubMed:20530735). Can also activate branched-chain fatty acids such as phytanic acid and pristanic acid (PubMed:10198260). May contribute to the synthesis of sphingosine-1-phosphate (PubMed:24269233). Does not activate C24 bile acids, cholate and chenodeoxycholate (PubMed:11980911). In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol (PubMed:11980911). However, it is not critical for THCA activation and bile synthesis in vivo (PubMed:20530735) , Exhibits both long-chain fatty acids (LCFA) transport activity and acyl CoA synthetase towards very long-chain fatty acids (PubMed:10198260, PubMed:21768100). Shows a preference for generating CoA derivatives of n-3 fatty acids, which are preferentially trafficked into phosphatidylinositol (PubMed:21768100) , Exhibits long-chain fatty acids (LCFA) transport activity but lacks acyl CoA synthetase towards very long-chain fatty acids [The Uniprot Consortium]
Schlagworte: SLC27A2, THCA-CoA ligase, Phytanate--CoA ligase, Arachidonate--CoA ligase, Fatty acid transport protein 2, Long-chain-fatty-acid--CoA ligase, Solute carrier family 27 member 2, Very long-chain acyl-CoA synthetase, Very long-chain-fatty-acid-CoA ligase, Lo
Hersteller: Absea
Hersteller-Nr: PQ-3963

Eigenschaften

Konjugat: No
Wirt: Human cells
Spezies-Reaktivität: human
MW: 57.5 kD
Format: Solution

Handhabung & Sicherheit

Lagerung: -20°C (avoid repeat freezing and thawing cycles)
Versand: -20°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Recombinant Human SLC27A2 Protein"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen